2014 Conference

Abstract: GRIPP2 (Guidance for Reporting Involvement of Patients and Public) provides consensus-based guidance on reporting patient and public involvement, with the intention of enhancing the quality and transparency of the patient and public involvement (PPI) evidence base. GRIPP 2 has been developed in collaboration with the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network and other collaborators, following the EQUATOR 18 step process. We undertook three rounds of a Delphi survey between September 2013 and February 2014 with 143 participants identified from key PPI networks, including academics, clinicians, public organisations (eg charities, funding organisations) and patients. A face-to-face consensus meeting was held after the Delphi survey was completed to gain consensus by discussion for items not reaching consensus in the Delphi, to tweak wording of items to improve comprehension, and to discuss dissemination of the GRIPP 2 checklist.

Response rates were high in each round of Delphi, with 86% (123) responding in Round 2 and 78% (112) responding in Round 3. A key outcome of Round 1 was the identification of a need for a long form of GRIPP 2 for papers focusing on PPI, and a short form of GRIPP 2 for papers where PPI is not the main focus, such as clinical trials. Participants were therefore asked to identify which items of importance for a short form version of GRIPP 2 in Round 2.

GRIPP 2 (long form and short form) is the first international guidance for the reporting of PPI. This presentation will describe its development, key components and future development.

Authors

Staniszewska ~ Sophie

Senior Research Fellow, Royal College of Nursing Research Institute, Warwick Medical School. Sophie Staniszewska leads the Patient and Public Involvement (PPI) and Patient's Experiences Programme at the Royal College of Nursing Research Institute (RCNRI), Warwick Medical School. Sophie is an INVOLVE Associate, a National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC) PPI Group member and co-chairs the Methods and Impact Sub-group of Health Technology International. Sophie focuses on developing the PPI evidence base.

View all articles by this author

« Go back